ATG5 and chronic myelogenous leukemia, BCR-ABL1 positive: Immunoblot analysis showed that siRNA-ATG5 selectively decreased the protein level of ATG5 in CML P#1 and P#2 cells when compared with the non-target control (Fig. 6).